<DOC>
	<DOCNO>NCT00002193</DOCNO>
	<brief_summary>The purpose study see safe effective add new protease inhibitor ( PI ) , 141W94 , anti-HIV regimen include 2 nucleoside reverse transcriptase inhibitor ( NRTIs ) .</brief_summary>
	<brief_title>Safety Effectiveness Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone Combination With 141W94 HIV-Infected Children Who Have Never Received Protease Inhibitors</brief_title>
	<detailed_description>In double-blind , placebo-controlled , pediatric study , 210 patient randomize receive 2 NRTIs plus either 141W94 placebo . Enrollment patient sequential : patient 13 18 year age enrol first , follow child &lt; 13 appropriate pediatric dose determine . Patients unable swallow capsule accrue liquid formulation become available .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>Amprenavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<criteria>Inclusion Criteria Your child may eligible study he/she : Is 6 month 18 year age . Is HIVpositive . Has viral load ( level HIV body ) great 10,000 copies/ml . Is able take medication mouth . Has consent parent legal guardian 18 . Has negative pregnancy test within 7 day study entry . Agrees practice abstinence use effective method birth control 1 month throughout study . Exclusion Criteria Your child eligible study he/she : Has serious illness , include lifethreatening infection chronic serious medical condition . Has opportunistic ( AIDSrelated ) infection serious bacterial infection . Is allergic NRTIs . Is breastfeed . Is unlikely complete study . Has receive certain medication . Has receive radiation therapy within past 4 month , need receive study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 1999</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>VX 478</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
</DOC>